Capricor Therapeutics (CAPR) Invested Capital (2010 - 2023)
Capricor Therapeutics (CAPR) posted quarterly Invested Capital of $18628.0 for Q2 2023, down 80.21% year-over-year from $94135.0 in Q2 2022, and little changed quarter-over-quarter from $18716.0 in Q1 2023.
Capricor Therapeutics (CAPR) Invested Capital (2010 - 2023) Analysis & Trends
Capricor Therapeutics' Invested Capital history runs 8 years deep, the most recent figure standing at $18628.0 for Q2 2023.
- In Q2 2023, Invested Capital fell 80.21% year-over-year to $18628.0; the TTM figure through Mar 2024 stood at $18628.0 (down 93.49% YoY), while the FY2022 annual figure was $89234.0, down 85.11% from the prior year.
- Invested Capital for Q2 2023 stood at $18628.0, roughly flat from $18716.0 in the prior quarter.
- The five-year high for Invested Capital was $599388.0 in Q4 2021, with the low at $18628.0 in Q2 2023.
- The 3-year median for Invested Capital is $89234.0 (2022), against an average of $211300.7.
- Peak annual rise in Invested Capital reached 80.21% in 2023, while the deepest fall reached 96.74% in 2023.
- Capricor Therapeutics' Invested Capital stood at $599388.0 in 2021, then plunged by 85.11% to $89234.0 in 2022, then sank by 79.12% to $18628.0 in 2023.
- Business Quant data shows CAPR's Invested Capital at $18628.0 in Q2 2023, $18716.0 in Q1 2023, and $89234.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 18,628.00 |
| Mar 31, 2023 | 18,716.00 |
| Dec 31, 2022 | 89,234.00 |
| Sep 30, 2022 | 84,156.00 |
| Jun 30, 2022 | 94,135.00 |
| Mar 31, 2022 | 574,848.00 |
| Dec 31, 2021 | 599,388.00 |
| Sep 30, 2017 | 14.16 Mn |
| Jun 30, 2017 | 14.16 Mn |
| Dec 31, 2013 | 41,855.00 |
| Sep 30, 2013 | 18,000.00 |
| Jun 30, 2013 | 13,200.00 |
| Mar 31, 2013 | 6,600.00 |
| Dec 31, 2012 | 16,139.00 |
| Sep 30, 2012 | 8,066.00 |
| Jun 30, 2012 | 36,448.00 |
| Mar 31, 2012 | 98,291.00 |
| Dec 31, 2011 | 38,892.00 |
| Sep 30, 2011 | 36,167.00 |
| Jun 30, 2011 | 37,371.00 |